Debt-to-Equity Ratio

Biogen's current Debt-to-Equity Ratio of 0.34x means the company uses $0.34 of debt for every $1 of shareholder equity—a measure of financial leverage that indicates lower reliance on borrowed funds.

This ratio sits below the healthcare sector median of 0.43x and places Biogen at the 45th percentile among its sector peers, meaning it is slightly less leveraged than the typical company in its industry. The metric shows no trend data: the year-over-year and quarter-over-quarter changes are both reported as N/A, and no historical values beyond the current reading are available for the last eight quarters. Given the low debt level relative to equity and the absence of a trend, the combination suggests a relatively conservative capital structure with limited immediate financial risk, but the lack of directional insight makes it difficult to assess whether leverage is increasing or declining. This metric supports the overall NEUTRAL verdict: the low leverage points to stability and lower default risk, offering no strong bullish or bearish signal on its own, and the missing trend prevents any additional conviction.

Frequently Asked Questions

Closest Sector Peers